Clinical Trial Update: Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer [Phase 3]

View source ↗

Summary

An open-label Phase 3 trial evaluating Sipuleucel-T in active surveillance patients with newly diagnosed prostate cancer has completed. The study results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• sipuleucel-T (sipuleucel-T)

Snippet

Sponsor: Dendreon | Conditions: Adenocarcinoma of the Prostate | Phase 3 | Status: COMPLETED | Results posted: 2024-10-08